ClinVar Miner

Submissions for variant NM_000257.4(MYH7):c.2513C>A (p.Pro838Gln) (rs397516153)

Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Laboratory for Molecular Medicine, Partners HealthCare Personalized Medicine RCV000151268 SCV000199188 likely pathogenic Hypertrophic cardiomyopathy 2013-08-27 criteria provided, single submitter clinical testing The Pro838Gln variant in MYH7 has now been identified by our laboratory as a de novo variant in 1 neonate with HCM. It has not been identified in large populati on studies. This variant was predicted to be pathogenic using a computational to ol clinically validated by our laboratory. This tool's pathogenic prediction is estimated to be correct 94% of the time (Jordan 2011). Additional computational analyses (biochemical amino acid properties, conservation, AlignGVGD, PolyPhen2, and SIFT) suggest that this variant may impact the protein, though this informa tion is not predictive enough to determine pathogenicity. In addition, another v ariant at this position, Pro838Leu, has been identified as a de novo variant in 2 infants with RCM (Karam 2008; LMM unpublished data) and is classified as patho genic by our laboratory. In summary, the available data suggests that the Pro838 Gln variant is likely pathogenic, though additional studies are required to full y establish its clinical significance.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.